Approval Of Medtronic’s Renal Denervation System Delayed By COVID-19
Executive Summary
Medtronic says that most of the clinical trials it is sponsoring are paused due to the pandemic, which means the completion of its PMA application for the Symplicity Spyral renal denervation system will be delayed.